Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 16.91
+0.49 (2.98%)
Jul 10, 2026, 3:05 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 10.06 billion as of July 10, 2026. Its market cap has increased by 2.18% in one year.
Market Cap
10.06B
Enterprise Value
7.31B
Revenue
1.20B
Ranking
n/a
PE Ratio
53.67
Stock Price
16.91
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 10.06B, a decrease of -64.22%. That is a compound annual growth rate of -20.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 10.06B | -9.23% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Furui Medical Science | 11.01B |
| Beijing Hotgen Biotech | 10.28B |
| Chengzhi | 10.12B |
| Jiangxi Fushine Pharmaceutical | 10.03B |
| Shanghai Medicilon | 9.95B |
| GemPharmatech | 9.52B |
| Chengdu Easton Biopharmaceuticals | 9.01B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.99B |